Low doses of monocrotaline in rats cause diminished bone marrow cellularity and compromised nitric oxide production by peritoneal macrophages

Journal of Immunotoxicology

Volumn 6, Issue 1, 2009, Pages 11-18

  Hueza, Isis M ^a   Benassi, Julia C ^a   Raspantini, Paulo C F ^a   Raspantini, Leonila E R ^a   Sá, Lilian R M ^a   Grniak, Silvana L ^a   Haraguchi, Mitsue ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BIOLÓGICO   (Brazil)

Author keywords

Bone marrow; Macrophages; Monocrotaline; Nitric oxide

Indexed keywords

MONOCROTALINE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE MARROW CELL; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROTALARIA; HUMORAL IMMUNITY; IMMUNE RESPONSE; INTOXICATION; LYMPHOID ORGAN; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

ADMINISTRATION, ORAL; ANIMAL STRUCTURES; ANIMALS; ANTIBODIES; ANTIBODY FORMATION; BODY WEIGHT; BONE MARROW; BONE MARROW CELLS; CELL COUNT; EATING; HYDROGEN PEROXIDE; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; IMMUNITY, INNATE; L-LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MONOCROTALINE; NITRIC OXIDE; PHAGOCYTOSIS; RATS; RATS, WISTAR; TETRADECANOYLPHORBOL ACETATE;

RATTUS; RODENTIA;

EID: 70350447814     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.1080/15476910802604259     Document Type: Article

References (47)

1. Bokhtiar, S. M., Gafur, M. A., and Rahman, A. B. 2003. Effects of Crotalaria and Sesbania aculeata green manures and N-fertilizer on soil fertility and the productivity of sugarcane. J. Agric. Sci. 140:305-309.
2. Byron, J. 1998. Pyrrolizidine alkaloids in eggs: New alkaloid found in potatoes. Food Chem. News 14:6-7.
3. Cheeke, P. R. (Ed.) 1998. Natural Toxicants in Feeds, Forages and Poisonous Plants. Danville: Interestate Publishers, pp. 479.
4. Chesney, C. F., Allen, J. R., and Hsu, I. C. 1974. Right ventricular hypertrophy in monocrotaline pyrrole-treated rats. Exp. Mol. Pathol. 20:257-268.
5. Culvenor, C. C., and Smith, L. W. 1963. Alkaloids of Crotalaria crispara F. Muell. ex Benth., the structures of cripatine and fulvine. Aust. J. Chem. 16:239-245.
6. Cunningham-Rundles, S., McNeeley, D. F., and Moon, A. 2005. Mechanisms of nutrient modulation of the immune response. J. Allergy Clin. Immunol. 115:1119-1128.
7. Eloff, J. N., Jansen Van Rijssen, F. W., Naude, T. W., and Joubert, J. P. J. 2003. What levels of potentially toxic seed should be allowed in grains in South Africa? I. Background and pyrrolizidine alkaloid-containing plants. S. Afr. J. Sci. 99:337-344.
8. Exon, J. H., Bussiere, J. L., and Mather, G. G. 1990. Immunotoxicity testing in the rat: An improved multiple assay model. Int. J. Immunopharmacol. 12:699-701.
9. Figueredo, M. L. A., Rodriguez, J., and Alfonso, H. A. 1987. Pathology of experimental acute intoxication of Crotalaria retusa and Crotalaria spectabillis in chickens. Rev. Cubana Ciencias Vet. 18:63-71.
10. Fu, P. P., Chou, M. W., Xia, Q., Yang, Y. C., Yan, J., Doerge, D. R., and Chan, P. C. 2001. Genotoxic pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides mechanisms leading to DNA adduct formation and tumorigenicity. Environ. Carcinog. Ecotoxicol. Rev. 19:353-386.
11. Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., and Tanneubaum, S. R. 1982. Analysis of nitrate, nitrite and [15N] nitrite in biological fluids. Anal. Biochem. 126:131-138.
12. Henderson, R. F., Benson, J. M., Hahn, F. F., Hobbs, C. H., Jones, R. K., Mauderly, J. L., McClellan, R. O., and Plckrell, J. A. 1985. New approaches for evaluation of pulmonary toxicity: Bronchoalveolar lavage fluid analysis. Fundam. Appl. Toxicol. 5:451-458.
13. Heron, I., and Berg, K. 1978. The actions of interferon are potentiated at elevated temperature. Nature 274:508-510.
14. Hincks, J. R., Kim, H. Y., Segall, H. J., Molyneux, R. J., Stermitz, F. R., and Coulombe, R. A. 1991. DNA cross-linking in mammalian cells by pyrrolizidine alkaloids: Structure-activity relationships. Toxicol. Appl. Pharmacol. 111:90-98.
15. Huxtable, R. J. 1990. Activation and pulmonary toxicity of pyrrolizidine alkaloids. Pharmacol. Ther. 47:371-389.
16. Idova, G., Cheido, M., and Devoino, L. 1997. Modulation of the immune response by changing neuromediator systems activity under stress. Int. J. Immunopharmacol. 19:535-540.
17. Kasahara, Y., Kiyatake, K., Tatsumi, K., Sugito, K., Kakusaka, I., Yamagata, S. I., Ohmori, S., and Kuriyama, T. 1997. Bioactivation of monocrotaline by P450 3A in rat liver. J. Cardiovasc. Pharmacol. 30:124-129.
18. Kim, H. Y., Stermitz, F. R., Molyneux, R. J., Wilson, D. W., Taylor, D., and Coulombe, R. A. 1993. Structural influences on pyrrolizidine alkaloid- induced cytopathology. Toxicol. Appl. Pharmacol. 122:61-69.
19. Lalich, J. J., and Merkow, L. 1961. Pulmonary arteritis produced in rats by feeding Crotolaria spectabilis. Lab. Invest. 10:744-750.
20. Lee, D. P., Skolnik, J. M., and Adamson, P. C. 2005. Pediatric phase I trials in oncology: An analysis of study conduct efficiency. J. Clin. Oncol. 23:8431-8441.
21. Letendre, L., Smithson, W. A., and Gilchrist, G. S. 1981. Activity of indicine N-oxide in refractory acute leukemia. Cancer 47:437-441.
22. Molyneux, R. J., and Roitman, J. N. 1980. Specific detection of pyrrolizidine alkaloids on thin-layer chromatograms. J. Chromatog. 195:412-415.
23. Molyneux, R. J., Roitman, J. N., Benson, M., and Lundin, R. E. 1982. [13C]-NMR spectroscopy of pyrrolizidine alkaloids. Phytochemistry 21:439-443.
24. Mukhopadhyay, S., Shah, M., Patel, K., and Sehgal, P. B. 2006. Monocrotaline pyrrole-induced megalocytosis of lung and breast epithelial cells: Disruption of plasma membrane and Golgi dynamics and an enhanced unfolded protein response. Toxicol. Appl. Pharmacol. 211:209-220.
25. Niwa, H., Ogawa, T., Okamoto, O., and Yamada, K. 1991. Alkylation of nucleosides by dehydromonocrotaline, the putative toxic metabolite of the carcinogenic pyrrolizidine alkaloid monocrotaline. Tetrahedron Lett. 32:927-930.
26. Nobre, D., Dagli, M. L., and Haraguchi, M. 1994. Crotalaria juncea intoxication in horses. Vet. Human Toxicol. 36:445-448.
27. Pan, L. C., Wilson, D. W., Lame, M. W., Jones, A. D., and Segall, H. J. 1993. Cor pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine. Toxicol. Appl. Pharmacol. 118:87-97.
28. Pereira, T. N., Webb, R. I., Reilly, P. E., Seawright, A. A., and Prakash, A. S. 1998. Dehydromonocrotaline generates sequence-selective N-7 guanine alkylation and heat and alkali stable multiple fragment DNA crosslinks. Nucleic Acids Res. 26:5441-5447.
29. Petry, T. W., Bowden, G. T., Huxtable, R. J., and Sipes, I. G. 1984. Characterization of hepatic DNA damage induced in rats by the pyrrolizidine alkaloid monocrotaline. Cancer Res. 44:1505-1509.
30. Pick, E., and Mizel, D. 1981. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture sing an automatic enzyme immunoassay. J. Immunol. Meth. 46:211-226.
31. Poster, D. S., Bruno, S., Penta, J., and MacDonald, J. S. 1981. Indicine-Noxide: A new anti-tumor agent. Cancer Treat. Rep. 65:1-2.
32. Prakash, A. S., Pereira, T. N., Reilly, P. E., and Seawright, A. A. 1999. Pyrrolizidine alkaloids in human diet. Mutat. Res. 443:53-67.
33. Rabinovitch, M., and Destefano, M. J. 1973a. Macrophage spreading in vitro: I. Inducers of spreading. Exp. Cell Res. 77:323-334.
34. Rabinovitch, M., and Destefano, M. J. 1973b. Macrophage spreading in vitro: II. Manganese and other metals as inducers or as co-factors for induced spreading. Exp. Cell Res. 79:423-430.
35. Roberts, N. J., Jr. 1991. Impact of temperature elevation on immunologic defenses. Rev. Infect. Dis. 13:462-472.
36. Roeder, E. 1995. Medicinal plants in Europe containing pyrrolizidine alkaloids. Pharmazie 50:83-98.
37. Ruffmann, R., Schlick, E., Tartaris, T., Budzynski, W., and Chirigos, M. A. 1987. Protein deficiency reduces natural anti-tumor immunity. Cancer Detect. Prevent. Suppl. 1:15-27.
38. Ruffmann, R., Schlick, E., Tartaris, T., Gruys, E., Welker, R. D., Saito, T., and Chirigos, M. A. 1985. Effects of protein depletion on NK cell cytotoxicity and bone marrow cellularity. Med. Oncol. Tumor Pharmacother. 2:195-202.
39. Russo, M., Teixeira, H. C., Marcondes, M. C., and Barbuto, J. A. 1989. Superoxide independent hydrogen peroxide release by activated macrophages. Braz. J. Med. Biol. Res. 22:1271-1273.
40. Sasaki, A., Doi, S., Mizutani, S., and Azuma, H. 2007. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats. Am. J. Physiol. Lung Cell Mol. Physiol. 292:L1480-1487.
41. Shah, M., Patel, K., and Sehgal, P. B. 2005. Monocrotaline pyrrole-induced endothelial cell megalocytosis involves a Golgi blockade mechanism. Am. J. Physiol. Cell Physiol. 288:850-862.
42. Srivastava, R. N., and Mohabbat, O. 1977. Veno-occlusive disease of the liver. Am. Heart J. 94:665.
43. Steenkamp, V., Stewart, M. J., and Zuckerman, M. 2000. Clinical and analytical aspects of pyrrolizidine poisoning caused by South African traditional medicines. Ther. Drug Monit. 22:302-306.
44. Tapiero, H., Mathe, G., Couvreur, P., and Tew, K. D. 2002. I Arginine. Biomed. Pharmacother. 56:439-445.
45. Wang, Y. P., Yan, J., Beger, R. D., Fu, P. P., and Chou, M. W. 2005. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo. Cancer Lett. 226:27-35.
46. Wilson, D. W., Segall, H. J., Pan, L. C., Lame, M. W., Estep, J. E., and Morin, D. 1992. Mechanisms and pathology of monocrotaline pulmonary toxicity. Crit. Rev. Toxicol. 22:307-325.
47. Whitehead, V. M., Bernstein, M. L., Vega, R., Vats, T., Dyment, P., Vietti, T. J., and Krischer, J. 1990. Phase I trial of indicine-N-oxide in children with leukemia and solid tumors: A Pediatric Oncology Group study. Cancer Chemother. Pharmacol. 26:377-379. (Pubitemid 20271545)